Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 26 2024
0mins
Source: accesswire
Webinar Invitation: Enlivex Therapeutics Ltd. is hosting a webinar on December 3, 2024, featuring CEO Oren Hershkovitz discussing their lead product Allocetra™, its clinical status, and future plans.
Product Overview: Allocetra™ is an innovative cell therapy aimed at reprogramming macrophages to treat inflammatory and autoimmune diseases, with promising results from Phase I/II trials targeting significant market opportunities.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
